XNYS · Healthcare · Drug Manufacturers - Specialty & Generic
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | Q1 2026 | 0.04 | -0.40 | -1100.00% | $608.1M | ❌ Miss | -14.10% | -23.51% | — |
| 2026-02-23 | Q4 2025 | 0.03 | 0.08 | +166.67% | $617.8M | ✅ Beat | -8.58% | +6.25% | +34.36% |
| 2025-11-03 |
| Q3 2025 |
| 0.10 |
| 0.09 |
| -10.00% |
| $599.0M |
| ❌ Miss |
| — |
| — |
| — |
| 2025-08-04 | Q2 2025 | 0.21 | 0.17 | -19.05% | $544.8M | ❌ Miss | -13.48% | -21.11% | -29.82% |
| 2025-02-24 | Q4 2024 | 0.10 | 0.11 | +10.00% | $481.1M | ✅ Beat | -22.32% | -20.72% | -34.98% |
| 2024-11-04 | Q3 2024 | 0.04 | 0.32 | +700.00% | $401.6M | ✅ Beat | -0.58% | +34.30% | +63.39% |
| 2024-02-26 | Q4 2023 | -0.02 | 0.01 | +150.00% | $246.6M | ✅ Beat | — | — | — |
| 2023-08-07 | Q2 2023 | -0.06 | -0.03 | +50.00% | $207.9M | ✅ Beat | -5.82% | -9.87% | -12.53% |
Showing last 8 quarters.